赫爾默裏奇和佩恩材料 HP 深 滬
等待開盤 09-17 09:30:00 美东时间
41.66
-1.790
-4.12%
華盛通- 最 高43.61
- 今 開43.11
- 成交量 125.93万股
- 最 低 41.155
- 昨 收 43.45
- 總市值 41.63亿
- 52周最高 48.17
- 市盈率 靜 --
- 換手率 1.26%
- 52周最低 20.655
- 委 比 -33.33%
- 總股本 9993.89万
- 歷史最高 94.30
- 量 比 1.20
- 振 幅 5.65%
- 歷史最低 3.82
- 每 手 1
- 風險率 6.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 齐声看好医药股！礼来、强生、默沙东目标价均获上调；小摩大幅上调Meta目标价至820美元
今日重点评级关注：康托·菲茨杰拉德：维持SOL Strategies"超配"评级，目标价从2.8美元升至6.2美元；康托·菲茨杰拉德：维持Sui Group Holdings"超配"评级，目标价从1.7美元升至3.4美元
09-11 14:30
Citigroup Maintains Neutral on Helmerich & Payne, Raises Price Target to $48
Citigroup analyst Scott Gruber maintains Helmerich & Payne (NYSE:HP) with a Neutral and raises the price target from $36 to $48.
09-04 22:57
Ascendis Pharma, Science Applications International And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling around 400 points on Monday. Shares of Ascendis Pharma A/S (NASDAQ:ASND) rose sharply on Monday. On Sunday, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) reached a binding settlement with Ascendis Pharma to resolve all global patent disputes rega...
08-31 22:30
August energy winners: Ten stocks posting double-digit monthly gains
As the month of August 2026 comes to a close, the broader stock market has exhibited a mix of late-summer consolidation and selective sector rotation. Investors continue to digest shifting macroeconom...
08-26 22:32
美股大行评级 | 塔吉特获13家大行上调目标价；Moderna携手默沙东齐获大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx Pharmaceutical"超配"评级，目标价从96美元升至103美元；Canaccord Genuity：维持Ultragenyx Pharmaceutical"买入"评级，目标价从81美元升至83美元
08-21 11:40
Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $41
Morgan Stanley analyst Joe Laetsch maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $36 to $41.
08-21 01:49
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
财报速睇 | 赫尔默里奇和佩恩材料 2026财年Q2营收10.35亿美元，同比下降0.6%；归母净利润0.76亿美元，扭亏为盈
华盛资讯8月7日讯，赫尔默里奇和佩恩材料公布2026财年Q2业绩，公司Q2营收10.35亿美元，同比下降0.6%，归母净利润0.76亿美元，扭亏为盈。
08-07 09:35
Helmerich & Payne shares are trading higher after the company reported better-than-expected Q3 sales results.
Helmerich & Payne shares are trading higher after the company reported better-than-expected Q3 sales results.
08-07 03:14
公司簡介
公司名稱
|
赫尔默里奇和佩恩材料
|
行業分類
|
油气设备
|
業務描述
|
Helmerich & Payne, Inc. engages in the provision of drilling solutions and technologies. It operates through the following segments: North America Solutions, Offshore Solutions, International Solutions, and Others. The North America Solutions segment focuses on the operation of the AC drive drilling rig fleet. The Offshore solutions segment refers to the seven platform rigs located in U.S. federal waters. The International Solutions segment includes Argentina, Colombia, Bahrain, and United Arab Emirates. The Other segment involves BENTEC manufacturing and engineering operations. The company was founded by Walter Hugo Helmerich II and William Payne in 1920 and is headquartered in Tulsa, OK.
|
美股大行评级 | 齐声看好医药股！礼来、强生、默沙东目标价均获上调；小摩大幅上调Meta目标价至820美元
今日重点评级关注：康托·菲茨杰拉德：维持SOL Strategies"超配"评级，目标价从2.8美元升至6.2美元；康托·菲茨杰拉德：维持Sui Group Holdings"超配"评级，目标价从1.7美元升至3.4美元
09-11 14:30
Citigroup Maintains Neutral on Helmerich & Payne, Raises Price Target to $48
Citigroup analyst Scott Gruber maintains Helmerich & Payne (NYSE:HP) with a Neutral and raises the price target from $36 to $48.
09-04 22:57
Ascendis Pharma, Science Applications International And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling around 400 points on Monday. Shares of Ascendis Pharma A/S (NASDAQ:ASND) rose sharply on Monday. On Sunday, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) reached a binding settlement with Ascendis Pharma to resolve all global patent disputes rega...
08-31 22:30
August energy winners: Ten stocks posting double-digit monthly gains
As the month of August 2026 comes to a close, the broader stock market has exhibited a mix of late-summer consolidation and selective sector rotation. Investors continue to digest shifting macroeconom...
08-26 22:32
美股大行评级 | 塔吉特获13家大行上调目标价；Moderna携手默沙东齐获大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx Pharmaceutical"超配"评级，目标价从96美元升至103美元；Canaccord Genuity：维持Ultragenyx Pharmaceutical"买入"评级，目标价从81美元升至83美元
08-21 11:40
Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $41
Morgan Stanley analyst Joe Laetsch maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $36 to $41.
08-21 01:49
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
财报速睇 | 赫尔默里奇和佩恩材料 2026财年Q2营收10.35亿美元，同比下降0.6%；归母净利润0.76亿美元，扭亏为盈
华盛资讯8月7日讯，赫尔默里奇和佩恩材料公布2026财年Q2业绩，公司Q2营收10.35亿美元，同比下降0.6%，归母净利润0.76亿美元，扭亏为盈。
08-07 09:35
Helmerich & Payne shares are trading higher after the company reported better-than-expected Q3 sales results.
Helmerich & Payne shares are trading higher after the company reported better-than-expected Q3 sales results.
08-07 03:14
派息除權日
|
每股總股息
| 派息日期 |
2026-08-18
|
0.25
|
2026-09-01
|
2026-05-18
|
0.25
|
2026-06-01
|
2026-02-13
|
0.25
|
2026-02-27
|
2025-11-18
|
0.25
|
2025-12-02
|
2025-08-15
|
0.25
|
2025-08-29
|
2025-05-15
|
0.25
|
2025-05-30
|
2025-02-14
|
0.25
|
2025-02-28
|
2024-11-18
|
0.25
|
2024-12-02
|
2024-08-16
|
0.42
|
2024-08-30
|
2024-05-16
|
0.42
|
2024-05-31
|
2024-02-12
|
0.42
|
2024-02-27
|
2023-11-17
|
0.42
|
2023-12-04
|
2023-08-16
|
0.49
|
2023-08-31
|
2023-05-17
|
0.49
|
2023-06-01
|
2023-02-13
|
0.49
|
2023-02-28
|
2022-11-14
|
0.49
|
2022-12-01
|
2022-08-16
|
0.25
|
2022-09-01
|
2022-05-12
|
0.25
|
2022-05-27
|
2022-02-10
|
0.25
|
2022-02-28
|
2021-11-22
|
0.25
|
2021-12-01
|
2021-08-16
|
0.25
|
2021-08-31
|
2021-05-14
|
0.25
|
2021-06-01
|
2021-02-11
|
0.25
|
2021-03-01
|
2020-11-12
|
0.25
|
2020-12-01
|
2020-08-14
|
0.25
|
2020-08-31
|
2020-05-08
|
0.71
|
2020-06-01
|
2020-02-07
|
0.71
|
2020-03-02
|
2019-11-07
|
0.71
|
2019-12-02
|
2019-08-09
|
0.71
|
2019-09-03
|
2019-05-10
|
0.71
|
2019-06-03
|
2019-02-07
|
0.71
|
2019-03-01
|
2018-11-08
|
0.71
|
2018-12-03
|
2018-08-16
|
0.71
|
2018-08-31
|
2018-05-17
|
0.70
|
2018-06-01
|
2018-02-09
|
0.70
|
2018-03-01
|
2017-11-10
|
0.70
|
2017-12-01
|
2017-08-16
|
0.70
|
2017-09-01
|
2017-05-17
|
0.70
|
2017-06-01
|
2017-02-09
|
0.70
|
2017-03-01
|
2016-11-08
|
0.70
|
2016-12-01
|
2016-08-11
|
0.70
|
2016-09-01
|
2016-05-11
|
0.69
|
2016-06-01
|
2016-02-10
|
0.69
|
2016-03-01
|
2015-11-10
|
0.69
|
2015-12-01
|
2015-08-12
|
0.69
|
2015-09-01
|
2015-05-13
|
0.69
|
2015-06-01
|
2015-02-11
|
0.69
|
2015-03-02
|
2014-11-12
|
0.69
|
2014-12-01
|
2014-08-13
|
0.69
|
2014-09-02
|
2014-05-13
|
0.63
|
2014-06-02
|
2014-02-12
|
0.63
|
2014-03-03
|
2013-11-13
|
0.50
|
2013-12-02
|
2013-08-13
|
0.50
|
2013-08-30
|
2013-05-13
|
0.15
|
2013-05-31
|
2013-02-13
|
0.15
|
2013-03-01
|
2012-11-13
|
0.07
|
2012-11-30
|
2012-08-13
|
0.07
|
2012-08-31
|
2012-05-11
|
0.07
|
2012-06-01
|
2012-02-13
|
0.07
|
2012-03-01
|
2011-11-10
|
0.07
|
2011-12-01
|
2011-08-11
|
0.07
|
2011-09-01
|
2011-05-11
|
0.06
|
2011-06-01
|
2011-02-11
|
0.06
|
2011-03-01
|
2010-11-10
|
0.06
|
2010-12-01
|
2010-08-11
|
0.06
|
2010-09-01
|
2010-05-12
|
0.05
|
2010-06-01
|
2010-02-10
|
0.05
|
2010-03-01
|
2009-11-10
|
0.05
|
2009-12-01
|
2009-08-12
|
0.05
|
2009-09-01
|
2009-05-13
|
0.05
|
2009-06-01
|
2009-02-11
|
0.05
|
2009-03-02
|
2008-11-12
|
0.05
|
2008-12-01
|
2008-08-13
|
0.05
|
2008-09-02
|
2008-05-13
|
0.05
|
2008-06-02
|
2008-02-13
|
0.05
|
2008-03-03
|
2007-11-13
|
0.05
|
2007-12-03
|
2007-08-13
|
0.05
|
2007-09-04
|
2007-05-11
|
0.05
|
2007-06-01
|
2007-02-13
|
0.05
|
2007-03-01
|
2006-11-13
|
0.05
|
2006-12-01
|
2006-08-11
|
0.05
|
2006-09-01
|
2006-05-11
|
0.08
|
2006-06-01
|
2006-02-13
|
0.08
|
2006-03-01
|
2005-11-10
|
0.08
|
2005-12-01
|
2005-08-11
|
0.08
|
2005-09-01
|
2005-05-11
|
0.08
|
2005-06-01
|
2005-02-11
|
0.08
|
2005-03-01
|
2004-11-10
|
0.08
|
2004-12-01
|
2004-08-11
|
0.08
|
2004-09-01
|
2004-05-12
|
0.08
|
2004-06-01
|
2004-02-11
|
0.08
|
2004-03-01
|
2003-11-12
|
0.08
|
2003-12-01
|
2003-08-13
|
0.08
|
2003-09-02
|
2003-05-13
|
0.08
|
2003-06-02
|
2003-02-12
|
0.08
|
2003-03-03
|
2002-11-13
|
0.08
|
2002-12-02
|
2002-08-13
|
0.08
|
2002-09-03
|
2002-05-13
|
0.08
|
2002-06-03
|
2002-02-13
|
0.08
|
2002-03-01
|
2001-11-13
|
0.08
|
2001-12-03
|
2001-08-13
|
0.08
|
2001-09-04
|
2001-05-11
|
0.08
|
2001-06-01
|
2001-02-13
|
0.08
|
2001-03-01
|
2000-11-13
|
0.08
|
2000-12-01
|
2000-08-11
|
0.08
|
2000-09-01
|
2000-05-11
|
0.07
|
2000-06-01
|
2000-02-11
|
0.07
|
2000-03-01
|
1999-11-10
|
0.07
|
1999-12-01
|
1999-08-11
|
0.07
|
1999-09-01
|
1999-05-12
|
0.07
|
1999-06-01
|
1999-02-10
|
0.07
|
1999-03-01
|
1998-11-10
|
0.07
|
1998-12-01
|
1998-08-12
|
0.07
|
1998-09-01
|
1998-05-13
|
0.07
|
1998-06-01
|
1998-02-11
|
0.07
|
1998-03-02
|
1997-11-12
|
0.13
|
1997-12-01
|
1997-08-13
|
0.13
|
1997-09-02
|
1997-05-13
|
0.13
|
1997-06-02
|
1997-02-12
|
0.13
|
1997-03-03
|
1996-11-13
|
0.13
|
1996-12-02
|
1996-08-13
|
0.13
|
1996-09-02
|
1996-05-13
|
0.13
|
1996-06-03
|
1996-02-13
|
0.13
|
1996-03-01
|
1995-11-13
|
0.13
|
1995-12-01
|
1995-08-11
|
0.13
|
1995-09-01
|
1995-05-09
|
0.13
|
1995-06-01
|
1995-02-09
|
0.13
|
1995-03-01
|
1994-11-08
|
0.13
|
1994-12-01
|
1994-08-09
|
0.13
|
1994-09-01
|
1994-05-10
|
0.12
|
1994-06-01
|
1994-02-09
|
0.12
|
1994-03-01
|
1993-11-08
|
0.12
|
1993-12-01
|
1993-08-10
|
0.12
|
1993-09-01
|
1993-05-10
|
0.12
|
1993-06-01
|
1993-02-08
|
0.12
|
1993-03-01
|
1992-11-09
|
0.12
|
1992-12-01
|
1992-08-10
|
0.12
|
1992-09-01
|
1992-05-11
|
0.12
|
1992-06-01
|
1992-02-10
|
0.12
|
1992-03-01
|
1991-11-08
|
0.12
|
1991-12-01
|
1991-08-09
|
0.12
|
1991-09-02
|
1991-05-09
|
0.12
|
1991-06-01
|
1991-02-11
|
0.12
|
1991-03-01
|
1990-11-08
|
0.12
|
1990-12-01
|
1990-08-09
|
0.11
|
1990-09-01
|
1990-05-09
|
0.11
|
1990-06-01
|
1990-02-09
|
0.11
|
1990-03-01
|
1989-11-09
|
0.11
|
1989-12-01
|
1989-08-09
|
0.10
|
1989-09-01
|
1989-05-09
|
0.10
|
1989-06-01
|
1989-02-09
|
0.10
|
1989-03-01
|
1988-11-01
|
0.10
|
1988-12-01
|
1988-08-09
|
0.10
|
1988-09-01
|
1988-05-10
|
0.10
|
1988-06-01
|
1988-02-06
|
0.10
|
1988-03-01
|
1987-11-09
|
0.10
|
1987-12-01
|
1987-08-10
|
0.10
|
1987-09-01
|
1987-05-11
|
0.10
|
1987-06-01
|
1987-02-09
|
0.09
|
1987-03-02
|
1986-11-07
|
0.09
|
1986-12-01
|
1986-08-11
|
0.09
|
1986-09-02
|
1986-05-09
|
0.09
|
1986-06-02
|
1985-11-08
|
0.09
|
1985-12-02
|
1985-08-09
|
0.09
|
1985-09-02
|
1985-05-09
|
0.09
|
1985-06-01
|
1985-02-08
|
0.09
|
1985-03-01
|
1984-11-08
|
0.09
|
1984-12-01
|
1984-08-09
|
0.09
|
1984-09-01
|
1984-05-10
|
0.09
|
1984-06-01
|
1984-02-07
|
0.09
|
1984-03-01
|
1983-11-09
|
0.09
|
1983-12-01
|
1983-08-10
|
0.08
|
1983-09-01
|
1983-05-10
|
0.08
|
1983-06-01
|
1983-02-07
|
0.08
|
1983-03-01
|
1982-11-08
|
0.08
|
1982-12-01
|
1982-08-10
|
0.07
|
1982-09-01
|
1982-05-11
|
0.07
|
1982-06-01
|
1982-02-08
|
0.07
|
1982-03-01
|
1981-11-06
|
0.07
|
1981-12-01
|
1981-08-11
|
0.05
|
1981-09-01
|
1981-05-13
|
0.05
|
1981-06-01
|
1981-02-06
|
0.05
|
1981-03-02
|
1980-11-10
|
0.05
|
1980-12-01
|
1980-08-11
|
0.09
|
1980-09-01
|
1980-05-19
|
0.09
|
1980-05-30
|
1980-02-13
|
0.09
|
1980-02-28
|
1979-11-08
|
0.09
|
1979-11-30
|
1979-08-14
|
0.12
|
1979-08-31
|
1979-05-08
|
0.12
|
1979-05-31
|
1979-02-08
|
0.12
|
1979-02-28
|
1978-11-13
|
0.12
|
1978-11-30
|
1978-08-17
|
0.09
|
1978-08-31
|
1978-05-15
|
0.09
|
1978-05-31
|
1978-02-09
|
0.09
|
1978-02-28
|
1977-11-03
|
0.09
|
1977-11-30
|
1977-08-08
|
0.07
|
1977-08-31
|
1977-05-08
|
0.07
|
1977-05-31
|
